KATHLEEN GOETZ

Corporate Board Profile

Tech Score: 0/100

abrdn Healthcare Investors

Filing Date	Source Excerpt
2024-04-22	Ms. Goetz brings to the Fund over 30 years of healthcare business and leadership experience. She serves on the Audit Committee and Valuation Committee of the Fund. The members of each Fund's Nominating and Corporate Governance Committee are Mr. Bailey, Ms. DiMartino, Ms. Goetz, Mr. Maher and Mr. Reit. The following table sets forth information regarding compensation: Kathleen Goetz total $121,000.

Filing Date

Source Excerpt

2024-04-22

Ms. Goetz brings to the Fund over 30 years of healthcare business and leadership experience. She serves on the Audit Committee and Valuation Committee of the Fund. The members of each Fund's Nominating and Corporate Governance Committee are Mr. Bailey, Ms. DiMartino, Ms. Goetz, Mr. Maher and Mr. Reit. The following table sets forth information regarding compensation: Kathleen Goetz total $121,000.

abrdn Life Sciences Investors

Filing Date	Source Excerpt
2024-04-22	Ms. Goetz brings to the Fund over 30 years of healthcare business and leadership experience. She brings extensive knowledge of healthcare markets, with leadership experience across product development, operational effectiveness, organizational governance and design, and marketing and sales strategy. She currently acts as a consultant and an advisor within the pharmaceutical, biotech, and medical technology sectors. Ms. Goetz was Vice President Head of Sales at Novartis Pharmaceuticals, a global healthcare company until 2019. She serves on the Audit Committee and Valuation Committee of the Fund.

Filing Date

Source Excerpt

2024-04-22

Ms. Goetz brings to the Fund over 30 years of healthcare business and leadership experience. She brings extensive knowledge of healthcare markets, with leadership experience across product development, operational effectiveness, organizational governance and design, and marketing and sales strategy. She currently acts as a consultant and an advisor within the pharmaceutical, biotech, and medical technology sectors. Ms. Goetz was Vice President Head of Sales at Novartis Pharmaceuticals, a global healthcare company until 2019. She serves on the Audit Committee and Valuation Committee of the Fund.

Data sourced from SEC filings. Last updated: 2026-02-03